InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2022-12-09 00:00:00 ET · period of report 2022-12-07 · accession 0001415889-22-012330 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-12-09 2022-12-07+ TECH Furlow Brenda S. SVP - GC S - Sale+OE $82.11 -8,250 26.1K -24% -$677.4K
DM 2022-12-09 2022-12-07+ TECH Furlow Brenda S. SVP - GC M - OptEx $31.26 +8,250 26.9K +44% +$257.9K
DM 2022-12-09 2022-12-07+ TECH Furlow Brenda S. SVP - GC M - OptEx $0.00 -8,250 37.2K -18% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-08 S D 7,450 $82.12 26,092 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 82.0000 to 82.4900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2 Common Common Stock 2022-12-08 M A 7,450 $31.26 33,542 D — —
3 Common Common Stock 2022-12-07 M A 800 $31.26 26,892 D — —
4 Common Common Stock 2022-12-07 S D 800 $82.01 26,092 D — —
5 Derivative Stock Options (Right to Buy) 2022-12-08 M D 7,450 $0.00 29,762 D $31.26 · — to 2024-08-09 7,450 Common Stock (F2) Fully exercisable.
6 Derivative Stock Options (Right to Buy) 2022-12-07 M D 800 $0.00 37,212 D $31.26 · — to 2024-08-09 800 Common Stock (F2) Fully exercisable.